These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2086244)

  • 1. Proenkephalin A-derived peptide E and its fragments alter opioid contractility in the small intestine.
    Davis TP; Hoyer GL; Davis P; Burks TF
    Eur J Pharmacol; 1990 Dec; 191(3):253-61. PubMed ID: 2086244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid activity of pro-enkephalin-derived peptides in mouse vas deferens and guinea pig ileum.
    Sánchez-Blázquez P; Garzón J
    Neurosci Lett; 1985 Nov; 61(3):267-71. PubMed ID: 3001596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue content of opioid peptides in the myenteric plexus-longitudinal muscle of guinea-pig small intestine.
    Corbett AD; McKnight AT; Kosterlitz HW
    J Neurochem; 1988 Jul; 51(1):32-7. PubMed ID: 3379412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide E and other proenkephalin-derived peptides are potent kappa opiate receptor agonists.
    Quirion R; Weiss AS
    Peptides; 1983; 4(4):445-9. PubMed ID: 6316294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proenkephalin A fragments exhibit spinal and supraspinal opioid activity in vivo.
    Dray A; Nunan L; Wire W
    J Pharmacol Exp Ther; 1985 Dec; 235(3):670-6. PubMed ID: 3001272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
    Pencheva N; Bocheva A; Dimitrov E; Ivancheva C; Radomirov R
    Eur J Pharmacol; 1996 May; 304(1-3):99-108. PubMed ID: 8813590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of a proenkephalin A-derived opioid peptide: BAM 18.
    Hurlbut DE; Evans CJ; Barchas JD; Leslie FM
    Eur J Pharmacol; 1987 Jun; 138(3):359-66. PubMed ID: 3040439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in opioid receptor selectivity following processing of peptide E: effect on gut motility.
    Davis TP; Gillespie TJ; Shook J; Kramer TH; Hoyer G; Hawkins K; Davis P; Yamamura HI; Burks TF
    Gastroenterology; 1991 Jun; 100(6):1603-15. PubMed ID: 1850373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioligands for probing opioid receptors.
    Paterson SJ; Corbett AD; Gillan MG; Kosterlitz HW; McKnight AT; Robson LE
    J Recept Res; 1984; 4(1-6):143-54. PubMed ID: 6098650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proenkephalin A fragment, peptide E: central processing and CNS activity in vivo.
    Davis TP; Porreca F; Burks TF; Dray A
    Eur J Pharmacol; 1985 May; 111(2):177-83. PubMed ID: 2990950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor.
    Corbett AD; Gillan MG; Kosterlitz HW; McKnight AT; Paterson SJ; Robson LE
    Br J Pharmacol; 1984 Sep; 83(1):271-9. PubMed ID: 6091824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacological profile of BAM 18.
    Hurlbut DE; Evans CJ; Barchas JD; Leslie FM
    NIDA Res Monogr; 1986; 75():81-4. PubMed ID: 2829012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for lack of modulation of mu-opioid agonist action by delta-opioid agonists in the mouse vas deferens and guinea-pig ileum.
    Elliott J; Traynor JR
    Br J Pharmacol; 1995 Mar; 114(5):1064-8. PubMed ID: 7780641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative potency of enkephalins and beta-endorphin in guinea-pig ileum, mouse vas deferens and rat vas deferens after the administration of peptidase inhibitors.
    Kuno Y; Aoki K; Kajiwara M; Ishii K; Oka T
    Jpn J Pharmacol; 1986 Jul; 41(3):273-81. PubMed ID: 3761746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
    Sagan S; Corbett AD; Amiche M; Delfour A; Nicolas P; Kosterlitz HW
    Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro pharmacology of the opioid peptides, enkephalins and endorphins.
    Waterfield AA; Smokcum RW; Hughes J; Kosterlitz HW; Henderson G
    Eur J Pharmacol; 1977 May; 43(2):107-16. PubMed ID: 17538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Met5-enkephalin-Arg6-Phe7 inhibition of noradrenaline and acetylcholine release from peripheral organs.
    Hársing LG; Rónai AZ; Somogyi GT; Umezawa H; Bajusz S; Vizi ES
    J Auton Pharmacol; 1984 Mar; 4(1):33-43. PubMed ID: 6325463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new endogenous opioid peptide from bovine adrenal medulla: isolation and amino acid sequence of a dodecapeptide (BAM-12P).
    Mizuno K; Minamino N; Kangawa K; Matsuo H
    Biochem Biophys Res Commun; 1980 Aug; 95(4):1482-8. PubMed ID: 7417331
    [No Abstract]   [Full Text] [Related]  

  • 19. Adrenal secretion of BAM-22P, a potent opioid peptide, is enhanced in rats with acute cholestasis.
    Swain MG; MacArthur L; Vergalla J; Jones EA
    Am J Physiol; 1994 Feb; 266(2 Pt 1):G201-5. PubMed ID: 8141292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the action of putative endogenous kappa-agonists, leumorphin and rimorphin in vitro.
    Suda M; Nakao K; Yoshimasa T; Ikeda Y; Sakamoto M; Yanaihara C; Yanaihara N; Numa S; Imura H
    Life Sci; 1983; 33 Suppl 1():275-8. PubMed ID: 6319876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.